The upregulation of the SDF-1 could result in increasing the population of OV6+ HCC cells, and by a specific CXCR4 inhibitor (AMD3100) or transfection of siRNA targeting CXCR4, the effect of SDF-1 was blocked. The gene discussed is CXCR4; the disease is hepatocellular carcinoma.